A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study von Drukker, C.A., Bueno‐de‐Mesquita, J.M., Retèl, V.P., Harten, W.H., Tinteren, H., Wesseling, J., Roumen, R.M.H., Knauer, M., Veer, L.J., Sonke, G.S., Rutgers, E.J.T., Vijver, M.J., Linn, S.C.

Volltext

Combining method of detection and 70-gene signature for enhanced prognostication of breast cancer von Lopes Cardozo, J. M. N., Schmidt, M. K., van ’t Veer, L. J., Cardoso, F., Poncet, C., Rutgers, E. J. T., Drukker, C. A.

Volltext

Outcome without any adjuvant systemic treatment in stage I ER+/HER2− breast cancer patients included in the MINDACT trial von Lopes Cardozo, J.M.N., Byng, D., Drukker, C.A., Schmidt, M.K., Binuya, M.A., van ’t Veer, L.J., Cardoso, F., Piccart, M., Smorenburg, C.H., Poncet, C., Rutgers, E.J.T.

Volltext

Prospective cost-effectiveness analysis of genomic profiling in breast cancer von Retèl, V.P, Joore, M.A, Drukker, C.A, Bueno-de-Mesquita, J.M, Knauer, M, van Tinteren, H, Linn, S.C, van Harten, W.H

Volltext

Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis von Drukker, C. A., Elias, S. G., Nijenhuis, M. V., Wesseling, J., Bartelink, H., Elkhuizen, P., Fowble, B., Whitworth, P. W., Patel, R. R., de Snoo, F. A., van ’t Veer, L. J., Beitsch, P. D., Rutgers, E. J. Th

Volltext

An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint® ) von Makama, M, Drukker, C.A, Rutgers, E.J.Th, Slaets, L, Cardoso, F, Rookus, M.A, Tryfonidis, K, Van't Veer, L.J, Schmidt, M.K

Volltext

Corrigendum to “An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature... von Makama, M., Drukker, C.A., Rutgers, E.J.Th, Slaets, L., Cardoso, F., Rookus, M.A., Tryfonidis, K., Van't Veer, L.J., Schmidt, M.K.

Volltext

Changes over time in the impact of gene‐expression profiles on the administration of adjuvant chemotherapy in estrogen receptor positive early stage breast cancer patients: A natio... von Kuijer, A., Drukker, C.A., Elias, S.G., Smorenburg, C.H., Th. Rutgers, E.J., Siesling, S., van Dalen, Th

Volltext

Long-term impact of the 70-gene signature on breast cancer outcome von Drukker, C. A., van Tinteren, H., Schmidt, M. K., Rutgers, E. J. Th, Bernards, R., van de Vijver, M. J., van’t Veer, L. J.

Volltext

Mammographic screening detects low-risk tumor biology breast cancers von Drukker, C. A., Schmidt, M. K., Rutgers, E. J. T., Cardoso, F., Kerlikowske, K., Esserman, L. J., van Leeuwen, F. E., Pijnappel, R. M., Slaets, L., Bogaerts, J., van’t Veer, L. J.

Volltext

Enrichment of high-grade tumors in breast cancer gene expression studies von van Seijen, M., Mooyaart, A. L., Mulder, L., Hoogstraat, M., Drukker, C. A., Loo, C. E., Pouw, B., Sonke, G. S., Wesseling, J., Lips, E. H.

Volltext

Risk estimations and treatment decisions in early stage breast cancer: Agreement among oncologists and the impact of the 70-gene signature von Drukker, C.A, van den Hout, H.C, Sonke, G.S, Brain, E, Bonnefoi, H, Cardoso, F, Goldhirsch, A, Harbeck, N, Honkoop, A.H, Koornstra, R.H.T, van Laarhoven, H.W.M, Portielje, J.E.A, Schneeweiss, A, Smorenburg, C.H, Stouthard, J, Linn, S.C, Schmidt, M.K

Volltext

Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherap... von Kuijer, A., van Bommel, A.C.M., Drukker, C.A., van der Heiden-van der Loo, M., Smorenburg, C.H., Westenend, P.J., Linn, S.C., Rutgers, E.J.Th, Elias, S.G., van Dalen, Th

Volltext

Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms von Drukker, C. A., Nijenhuis, M. V., Bueno-de-Mesquita, J. M., Retèl, V. P., van Harten, W. H., van Tinteren, H., Wesseling, J., Schmidt, M. K., van’t Veer, L. J., Sonke, G. S., Rutgers, E. J. T., van de Vijver, M. J., Linn, S. C.

Volltext

A breast cancer gene classification for indolent disease von Delahaye, L, Drukker, C, Dreezen, C, Witteveen, A, Chan, B, Snel, M, Beumer, I, Neijenhuis, S, van “t Veer, L, Glas, A

Volltext

Paraneoplastic gastro-intestinal anti-Hu syndrome in neuroblastoma von Drukker, C.A.M., Heij, H.A., Wijnaendts, L.C.D., Verbeke, J.I.M.L., Kaspers, G.J.L.

Volltext

Erratum to: Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis von Drukker, C. A., Elias, S. G., Nijenhuis, M. V., Wesseling, J., Bartelink, H., Elkhuizen, P., Fowble, B., Whitworth, P. W., Patel, R. R., de Snoo, F. A., van’t Veer, L. J., Beitsch, P. D., Rutgers, E. J. Th

Volltext

Borderline and malignant phyllodes tumors of the breast: a population-based study of all cases in the Netherlands 1989–2020 von Bartels, S., van Olmen, J., Bekers, E., Drukker, C., van Duijnhoven, F.

Volltext

Agreement on risk assessment and chemotherapy recommendations among breast cancer specialists: a survey within the MINDACT cohort von Lopes Cardozo, J., Veira, S., Ait Hassou, L., Uwimana, A., Božović-Spasojević, I., Bogaerts, J., Cardoso, F., Schmidt, M., Rutgers, E., Poncet, C., Drukker, C.

Volltext

Screen-detected breast cancers have different tumor biology and better prognosis compared to interval breast cancers von Cardozo, J.Lopes, Schmidt, M., van ’t Veer, L., Cardoso, F., Poncet, C., Rutgers, E., Drukker, C.

Volltext